Overview Fundamentals API Earnings EOD API Sample Code Pricing

Instil Bio Inc. (TIL NASDAQ) stock market data APIs

$73 8.02(12.3%) as of September 16, 2024
Price chart is built with Anychart

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Instil Bio Inc. Financial Data Overview

64.985
73
-
76.1279
58.88
6.07-92
550 M
6 504 K
0
-2.29
1.216
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TIL',
Type: 'Common Stock',
Name: 'Instil Bio Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZGYN521',
ISIN: NULL,
CUSIP: NULL,
CIK: '1789769',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-03-19',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Instil Bio Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -66 022 000
  • Earnings Per Share -18.39
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Instil Bio Inc. Earnings via APIs

  • Latest Release 2024-08-13
  • EPS/Forecast -2.98

Get Instil Bio Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com